Post-IO Curative Treatment Conversion May Prolong Survival in Liver Cancer

Curative treatment conversion (CTC), although infrequent, correlated with significantly improved survival in patients who received prior immunotherapy for hepatocellular carcinoma (HCC), according to findings from a representative cohort study…

Continue Reading